2 H 2 O) labeling method recently developed to measure cell proliferation in vivo is applied here to the measurement of murine epidermal cell turnover and to investigate conditions in which keratinocyte proliferation is either inhibited or stimulated. The technique is based on incorporation of 2 H 2 O into the deoxyribose moiety of deoxyribonucleotides in dividing cells. Label incorporation and die-away studies in cells isolated from C57BL/6J mouse epidermis revealed the replacement rate to be 34%-44% per wk (half-life of 1.6-2 wk). The kinetics provided evidence of a non-proliferative subpopulation of cells (10%-15% of the total) within the epidermis. Topical administration of 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate for 3 wk increased epidermal cell proliferation by 55% in SENCAR mice. Topical addition of lunasin, an anti-mitotic agent from soy, decreased epidermal cell proliferation modestly though significantly (16% given alone, 9% given with carcinogens). Caloric restriction (by 33% of energy intake) for 4 wk decreased the epidermal cell proliferation rate by 45% in C57BL/6J mice. In summary, epidermal cell proliferation can be measured in vivo using 2 H 2 O labeling in normal,
The kinetics of skin cell turnover are of interest for a variety of physiologic and pathologic conditions, including skin cancer, wound healing, and psoriasis (Weinstein et al, 1985) . The skin is a continuously self-renewing organ, with a complex, multilayered kinetic organization. The epidermis contains mainly keratinocytes, along with a minor population of dendritic cells, stem cells, and possibly a pool of quiescent cells (Dover, 1993; Haake et al, 2001) . Keratinocytes originate in the basal layer of the epidermis, through division of a population of stem cells. The daughter cells then divide several times as transit amplifying cells, which lose proliferative capacity and differentiate into post-mitotic, keratinrich cells as they migrate upward to the spinous layer of the epidermis. As these cells continue their transit through the granular layer, they become anucleate and form the uppermost, cornified layers which ultimately are sloughed off (Dover, 1993; Haake et al, 2001) . Turnover of the epidermis allows the organ to maintain its barrier function, repair injured skin in wound healing, and respond to stimuli that promote or inhibit cell proliferation.
The kinetics of cells, keratin, and lipids in the skin could provide useful information about skin biology in health and disease. Previous studies, however, have yielded inconsistent measurements of epidermal kinetics (Dover, 1993; Fairley and Zivony, 2001) . Estimates of epidermal cell transit time have ranged from 5 to 11 d in mouse dorsum (Downes et al, 1967; Potten, 1975; Jensen and Esterly, 1977) and from 12 to 48 d in human skin (Epstein and Maibach, 1965; Weinstein and Van Scott, 1965; Halprin, 1972; Plewig and Braun-Falco, 1975) . Reported human epidermal cell turnover times have ranged from 154 to 641 h (Epstein and Maibach, 1965; Christophers and Schaumloffel, 1967) to 71 d (Halprin, 1972) . It has also been noted (Clausen et al, 1983) that some keratinocytes in S-phase do not incorporate labeled deoxyribonucleoside precursors, which could complicate interpretation of labeling experiments with 3 Hthymidine ( 3 HdT) or bromodeoxyuridine (BrdU). Differences among animal models, sites of skin sampled, and methodologies could therefore have contributed to variations in kinetic measurements of epidermal cells. A reliable and reproducible measure of keratinocyte proliferation would be useful for understanding many aspects of normal skin biology.
There are also uncertainties regarding the extent of keratinocyte turnover in various skin diseases. Hyper-proliferation may represent a risk factor for skin cancer and occurs in physiologic conditions, such as wound healing and altered permeability barrier function (Proksch et al, 1991) , as well as pathological conditions, such as psoriasis (Weinstein and Van Scott, 1965; Weinstein et al, 1985) . The effects of chemopreventive or anti-psoriatic agents on keratinocyte proliferation, for example, would be of interest to measure if an appropriate assay were available.
We have recently developed a method for measuring cell proliferation in vivo using stable isotope labeling and mass spectrometric analysis (Fig 1a) (Neese et al, 2001 (Neese et al, , 2002 . This technique is based on endogenous labeling of DNA in dividing cells through the de novo nucleotide synthesis pathway, the contribution of which is relatively constant and unaffected by availability of extracellular deoxyribonucleosides or by label reincorporation (Neese et al, 2001 (Neese et al, , 2002 . Other technical advantages of this approach have been described elsewhere (Neese et al, 2001 (Neese et al, , 2002 . A particularly convenient approach is to label with heavy water ( 2 H 2 O), which allows long-term labeling studies at constant precursor pool enrichments by administration of 2 H 2 O in drinking water (Neese et al, 2002; Collins et al, 2003; Kim et al, 2004) . After 2 H 2 O administration, the cells of the tissue of interest are isolated, the DNA is extracted, and a derivative of the deoxyribose moiety of purine deoxyribonucleosides is analyzed for 2 H enrichment by gas chromatography/mass spectrometry (GC/MS). A tissue that is nearly fully replaced, such as bone marrow or blood monocytes, is then used as a reference value for the calculation of fractional replacement of cells in the tissue of interest. This approach has been successfully applied to measure turnover of T cells, adipocytes, colonocytes, leukemic cells, mammary epithelial cells, and other cells (Macallan et al, 1998; Chu et al, 1999; Hellerstein et al, 1999; Antelo et al, 2000; Kim et al, 2000; McCune et al, 2000; Misell et al, 2000; Mohri et al, 2000; Schwartz et al, 2003; Strawford et al, 2004; Kim et al, 2004, in press ). Stable isotope labeling is safe for use in humans and yields highly reproducible, quantitative measurements (Neese et al, 2001 (Neese et al, , 2002 . Here, we demonstrate the feasibility of this method for the study of epidermal cell turnover, including investigation of conditions in which epidermal cell proliferation is either inhibited or stimulated in appropriate animal models. Whole skin proliferation was also measured in mice given 2 H 2 O. Whole skin, which includes dermis as well as epidermis, gave about 50% lower proliferation rates than epidermis alone (24.0% versus 48.8% new cells after 2 wk), indicating that cells in the dermis (primarily fibroblasts) proliferate at a lower rate than epidermal keratinocytes, and that these layers need to be separated to allow accurate measurement of epidermal cell kinetics. Label decay (dilution) kinetics in epidermal cells from normal C57BL/6J mice indicated a turnover rate of 44% per wk (half-life of 1.6 wk) (Fig 2c) . These results are similar to the label incorporation results (Fig 2a) . Enrichment of DNA in epidermal cells declined rapidly during the first 4 wk of label die-away, but a low level of isotopic labeling persisted 11 wk after discontinuing 2 H 2 O intake (Fig 2c) . The latter finding suggests that there is a pool of slowly cycling, label-retaining cells in epidermis--that is, two pools of epidermal cells are present with distinct kinetics, as has been shown previously with stable isotope labeling for T cells (Hellerstein et al, 2003) , bone marrow precursor cells (Schwartz et al, 2000 (Schwartz et al, , 2003 , and colon epithelial cells (Kim et al, 2004 H 2 O for 2 wk (this timing based on the results from the label incorporation studies in normal mice) and were given topical carcinogen applications. DMBA and TPA application for 3 wk resulted in 55% higher fractional epidermal cell proliferation rates compared with vehicletreated mice (Fig 3a, po0 .05). Interestingly, the fractional replacement of the epidermal cells in carcinogen-treated mice approached 100%, which suggests that non-proliferative or slowly cycling cell populations in epidermis were also activated by the treatment with DMBA and TPA.
Results
Lunasin reduces epidermal cell proliferation The effect of topical administration of the anti-mitotic agent lunasin, derived from soybean (Galvez and de Lumen, 1999; Galvez et al, 2001) , was also tested in SENCAR mice. We compared SENCAR mice with vehicle treatment (N), topical lunasin treatment alone (L), carcinogen treatment alone (C), or lunasin plus carcinogen treatment (CL) (n ¼ 6 per group). With lunasin applications at 0.625 mg per mL to 3 cm 2 twice weekly for 4 wk, the L group exhibited a statistically significant 16% decrease in epidermal cell proliferation compared with the N group (Fig 3a) . CL mice also exhibited a small but significant 9% decrease in epidermal cell proliferation rate compared with the C group (Fig 3a) . These results show that 4 wk of lunasin treatment exerted a modest but significant anti-proliferative effect on keratinocytes Other SENCAR mice were given vehicle instead of carcinogen and were also treated with topical lunasin (L) or vehicle (N). 2 H 2 O label was administered during the 2 wk prior to euthanasia (see Fig 1a) . Fractional replacement (f) was determined as described in Fig 2a leg in vivo in both normal and carcinogen-treated SENCAR mice, and that these anti-proliferative affects were detectable using the 2 H 2 O labeling technique.
Caloric restriction (CR) markedly reduces epidermal cell proliferation It has previously been shown that CR reduces cell proliferation in various tissues, including the skin (Lok et al, 1990) . We studied the effects of CR (reduction in energy intake by 33%) for 4 wk in female C57BL/6 mice. After 4 wk of diet, calorically restricted mice had lost 18% of body weight and weighed 28% less than control ad libitum (AL) fed mice (14.4 g versus 20.0 g). Calorically restricted and control mice were given 2 H 2 O for 2 wk. CR significantly reduced epidermal cell proliferation (by 45%) compared with AL fed mice (Fig 3b, p ¼ 0.0004 ), indicating that CR has an inhibitory effect on keratinocyte proliferation.
Discussion
We describe and validate here a relatively simple method for measuring the proliferation and die-away kinetics of keratinocytes (epidermal cells) in rodents. This 2 H 2 O labeling technique has previously been shown to be highly reproducible and sensitive to relatively small changes in cell proliferation in other tissues (Neese et al, 2001 (Neese et al, , 2002 . The results presented here confirm that 2 H 2 O labeling of DNA in epidermal cells is also extremely sensitive to factors that increase or decrease cell proliferation.
Previous methods of measuring cell proliferation include static markers, such as Ki67 or PCNA staining (Mathews et al, 1984; Schluter et al, 1993) . These techniques do not reveal the actual rate at which cells are progressing through the cell cycle and completing mitotic cell division, however. Cell cycle markers are expressed in cells that are arrested in G 1 /S, for example, so that an agent that reduces cell proliferation by acting at the G 1 /S check-point will appear to increase the cycling fraction, based on Ki67 staining (Hellerstein, 1999) . Previously available dynamic measurements, such as the incorporation of BrdU and 3 HdT into cellular DNA, also have limitations. These reagents are toxic and mutagenic and, at high doses or after prolonged administration, may impair cell division or kill susceptible cells (Rocha et al, 1990; Asher et al, 1995) . Moreover, incorporation of these pyrimidine deoxynucleoside precursors into DNA occurs via nucleoside salvage pathways, the activity of which is highly variable and influenced by a number of factors, including the efficiency of nucleoside uptake by different cells and the availability of extracellular deoxyribonucleosides in the tissue (Cohen et al, 1983; Reichard, 1988; Rocha et al, 1990; Hellerstein, 1999) . These variables introduce noise and systematic confounding effects into measurements of cell proliferation from pyrimidine deoxyribonucleosides. Moreover, label decay results are particularly difficult to interpret after BrdU and 3 HdT labeling. Because these reagents tag cell lineages during cell division, daughter cells remain ''positive'' for several generations (Cohen et al, 1983; Reichard, 1988) , which complicates interpretation of cell death during the label decay phase (Hellerstein, 1999) . In addition, it has been noted in the past that some keratinocytes in S-phase do not incorporate labeled deoxyribonucleoside precursors into DNA (Clausen et al, 1983) . In contrast, the 2 H 2 O endogenous labeling method is safe, operates through the constitutive and relatively invariant de novo nucleoside synthesis pathway (Macallan et al, 1998; Hellerstein, 1999) , and does not depend on the deoxyribonucleoside salvage pathway, thereby yielding highly reproducible results (Neese et al, 2001 (Neese et al, , 2002 .
Our demonstration of a statistically significant 9%-16% inhibitory effect of topical lunasin on keratinocyte proliferation in vivo with a relatively small number of animals (six per group , Fig 3a) affirms the reproducibility and power of this 2 H 2 O labeling approach. The precision and ease of this technique could facilitate future high-throughput evaluations of agents intended to alter keratinocyte proliferation (Gijbels et al, 2000; Pol et al, 2003; van de Kerkhof and Vissers, 2003) .
Lunasin decreased keratinocyte proliferation significantly in both normal and carcinogen-treated SENCAR mice (Fig  3a) . The SENCAR mouse with topical chemical carcinogen treatment is a commonly used model of skin cancer (Chen et al, 1995; Galvez et al, 2001) . It is worth pointing out that the 2 H 2 O labeling method was able to detect a dramatic increase in epidermal cell proliferation rate within 3 wk of carcinogen treatment. Some traditional studies using the SENCAR mouse model have relied on papilloma formation as an indicator of carcinogenesis, a process that can take up to 20 wk to develop (Galvez et al, 2001) . In contrast, the 2 H 2 O labeling method allows sensitive detection of changes in epidermal cell proliferation within a much shorter time period. This feature may prove useful for evaluating the efficacy of chemopreventive agents with anti-promotional/ anti-proliferative actions, such as lunasin (Galvez and de Lumen, 1999; Galvez et al, 2001 ). In addition, the finding of nearly 100% fractional replacement of epidermal cells in carcinogen-treated epidermis suggests that normally quiescent cells are included among the targets of cutaneous carcinogens, consistent with previous hypotheses (Morris et al, 1988 (Morris et al, , 1997 Morris 2000) .
We also demonstrated clearly that CR by 33% significantly decreases epidermal cell proliferation in C57Bl/6J mice, compared with AL fed control mice (45% reduction, Fig 3b) . This finding is consistent with a previous study in which 25% CR regimen resulted in a 2-fold reduction in skin cell proliferation in Swiss Webster mice, as measured by 3 HdT labeling (Lok et al, 1990) . CR by 30% has been reported to decrease keratinocyte proliferation and papilloma formation in NMRI mice treated with topical carcinogens (Fischer and Lutz, 1998) . Decreased rates of cell proliferation may in part mediate the reduction in carcinogenesis observed in CR studies, through inhibition of promotion (Hursting and Kari, 1999; Hursting et al, 2003) . Measurement of keratinocyte proliferation may prove useful as an objective biomarker for investigating the anti-carcinogenic mechanisms and mediators of CR (Hsieh and Hellerstein, unpublished observations (Bickenbach, 1981; Tani et al, 2000; Potten and Booth, 2002) . The complementary finding from the label die-away study that a small fraction of cells retained their label 11 wk after discontinuing label (Fig 2c) provides additional evidence for a slow turnover subpopulation, such as stem cells, in the tissue. Previous results with 3 HdT labeling suggest that label-retaining cells comprise 1%-10% of the basal layer in the epidermis (Bickenbach, 1981; Tani et al, 2000; Potten and Booth, 2002) . Enrichments in keratinocyte DNA (Fig 2c) fell from 5.6% to 0.3% (more precisely, from 7.0% at peak labeling [not shown] to 0.3%, as Fig 2c starts 1 wk after discontinuing 2 H 2 O intake). Thus, 4%-5% of labeled cells remained after 11 wk, which is also within the range of the 10%-15% unlabeled cells at 6 wk of label incorporation (Fig 2a) . The numbers should not be overinterpreted, however, because unlabeled cells after 6 wk of 2 H 2 O administration (Fig 2a) are not necessarily all stem cells (some could be Langerhans cells, etc.). In addition, it is safe to say that not all stem cells will have divided during the 4-6 wk 2 H 2 O intake period, as the lifespan of their daughter cells is 6-12 wk (Fig 2c) , in addition to the possibility that a subset may be quiescent at any given time. Longer 2 H 2 O labeling periods might therefore result in more label-retaining cells (Collins et al, 2003) . It is also possible that some recently divided cells could be non-stem (i.e., Langerhans cells, etc.) or that there could also be degrees of ''stemness'', wherein cells that do not divide during 2 H 2 O intake are more quiescent than the set of cells that divided over 4 wk. In any case, stable isotope labeling of keratinocytes may be used as a tool to explore the ''stemness'' of cells with different phenotypic markers within the epidermis, as has been performed for colon epithelial cells (Kim et al, 2004) , lymphocytes (Hellerstein et al, 2003) , and bone marrow progenitor cells (Schwartz et al, 2000 (Schwartz et al, , 2003 . Epidermal stem cells are of interest, as they have been implicated as the targets of carcinogenesis (Morris et al, 1988 (Morris et al, , 1997 Morris 2000) .
In summary, we demonstrate here that keratinocyte proliferation can be measured in vivo in rodents using the 2 H 2 O stable isotope labeling method in normal, hyper-and hypoproliferative conditions. Potential applications of the method include the pathophysiology of diseases such as psoriasis and carcinogenesis, the physiology of wound healing, inquiries into basic skin biology and stem cell biology, relatively high-throughput testing of anti-proliferative pharmaceutical agents, and other interventions such as CR that are aimed at altering keratinocyte turnover.
Materials and Methods
Animal studies and administration of heavy water Eight-weekold female C57BL/6J mice (The Jackson Laboratory, Bar Harbor, Maine) were used. Mice received an intraperitoneal injection of isotonic 100% 2 H 2 O (Cambridge Isotope Laboratories, Cambridge, Massachusetts) to bring their 2 H 2 O content in body water up to 2.5%. For the label incorporation studies, mice were subsequently maintained AL on drinking water that contained 4% 2 H 2 O for 1, 2, 3, 4, 5, and 6 wk (n ¼ 3 per time point). For the label die-away studies, mice were maintained on 4% 2 H 2 O for 4 wk, after which time they were given unlabeled drinking water for 1, 2, 4, 8, and 12 wk (n ¼ 3 per time point). The mice were then euthanized by cervical dislocation and cardiac puncture under isoflurane anesthesia.
All procedures were approved by the University of California at Berkeley Animal Use Committee.
Epidermal cell and bone marrow cell isolation The method for epidermis isolation was adapted from previous techniques (Barlow and Pye, 1980; Dlugosz et al, 1995; Inokuchi et al, 1995) . Hair was removed post-mortem from skin of the dorsum of the mice by application of a hair remover lotion (Nair, Carter Products, New York, New York). After the lotion was cleaned off using an alcohol swab, a piece of skin from mouse dorsum was dissected (about 3 cm 2 ). The skin was rinsed with phosphate buffer saline (Gibco, Grand Island, New York), divided into three smaller pieces, immersed in dispase II (Roche, Indianapolis, Indiana), and incubated for 3.5 h at 371C on a shaker. The epidermis could then be peeled cleanly from the dermis as thin white sheets. Femurs were also collected, and bone marrow was flushed out using a needle and syringe containing PBS, as previously described (Macallan et al, 1998) .
Measurement of isotopic enrichments DNA After isolation of epidermal and bone marrow cells, genomic DNA was prepared as described previously McCune et al, 2000) . In brief, DNA was enzymatically hydrolyzed to free deoxyribonucleosides. Treatment with a cation resin (Bio-Rad Laboratories, Hercules, California) releases the deoxyribose (dR) moiety, which is then converted to the pentane-tetraacetate (PTA) derivative by sodium borohydride reduction (Sigma-Aldrich Corp., St Louis, Missouri) (Neese et al, 2001) . PTA was analyzed by GC/MS, using a model 5973 mass spectrometer and model 6890 gas chromatograph (Agilent, Inc., Palo Alto, California). Deuterium incorporation was determined from the abundance of m/z 246 (M þ 1 species) relative to m/z 245 (M þ 0 species) in samples, corrected for natural abundance (baseline) values, to calculate excess M þ 1 (EM 1 ) abundance, as previously described (Neese et al, 2001 (Neese et al, , 2002 In the label incorporation studies, epidermal DNA enrichment was compared with bone marrow DNA enrichment, the latter representing a nearly fully replaced tissue (Neese et al, 2002; Collins et al, 2003) , to calculate by comparison the fractional replacement of epidermal cells.
Fraction of new cells ðfÞ ¼
dR enrichment ðEM 1 Þ; epidermal cells dR enrichment ðEM 1 Þ; bone marrow cells Based on previously performed label incorporation and die-away studies, approximately 5% of bone marrow cells are quiescent over a 1-4-wk study period (Neese et al, 2002; Collins et al, 2003) . These observations are also consistent with estimates of maximal possible label incorporation of 2 H 2 O into DNA in bone marrow cells, based on combinatorial calculations of deuterium mass isotopomer abundances in deoxyribose (Neese et al, 2002; Hellerstein and Neese, unpublished observations) . The impact of incomplete turnover of the reference tissue (bone marrow) on fractional replacement is therefore modest but real (i.e., if the denominator is 5% too low, the fractional replacement value calculated will be roughly 5% too high). It should be noted that the shape of the curve, and thus the replacement rate constant or half-life, is not affected by the denominator used, however.
Body water Enrichment of
2 H 2 O in body water from blood was measured by a GC/MS technique that we have previously developed (Neese et al, 2001) . Standard curves are generated by mixing 100% 2 H 2 O with natural abundance H 2 O in known proportions. Blood obtained from cardiac puncture was centrifuged to collect serum, which was then reacted with calcium carbide chips (Sigma) as described (Collins et al, 2003 ). Released acetylene gas was then injected in a vial containing carbon tetrachloride (Sigma) and bromine (Sigma) for 2 h, generating tetrabromoethane. Cyclohexene (Sigma) in carbon tetrachloride was then added to the samples, which were analyzed by GC/MS (selected ion monitoring of m/z 265 and 266) (Neese et al, 2001 SENCAR mice and topical carcinogen application (Fig  1b) Eight-week-old female SENCAR mice (National Cancer Institute, Bethesda, Maryland) were acclimated for a week before starting on an AL soy-free diet of AIN-93M chow (Bio-Serv, Frenchtown, New Jersey). At 10 wk of age, mice were randomly divided into four treatment groups (n ¼ 6 per group): carcinogen (C), lunasin (L), carcinogen plus lunasin (CL), and neither (N). During week 1, twice weekly lunasin (Research Genetics, Huntsville, Alabama) or vehicle treatments were begun. Lunasin (250 mg per wk) in ethanol was applied on the shaven backs (about 3 cm 2 area) of groups L and CL, whereas groups C and N received ethanol application (vehicle) alone. During week 2, twice weekly carcinogen treatments were started, administered 4 h after lunasin or vehicle treatments. DMBA (Sigma) in acetone (20 mg per 200 mL) was applied one time and TPA (Sigma) in acetone (1 mg per 200 mL) was subsequently applied twice weekly for groups C and CL, whereas groups L and N received acetone (vehicle) only. The lunasin, TPA and vehicle treatments were continued until the end of the study (a total of 4 wk). Two weeks after beginning the lunasin or vehicle administration protocol, mice were given an intraperitoneal injection of 2 H 2 O (2.5% body water) and maintained on 4% 2 H 2 O in drinking water, as described above, for the remaining 2 wk until euthanization. Epidermal cells were isolated and DNA enrichments were measured.
Caloric restriction regimen Eight-week-old female C57BL/6J mice (The Jackson Laboratory) were divided into two diet groups (n ¼ 4 per group): 33% CR and AL fed. AL mice were fed a semipurified AIN-93M diet, whereas CR mice were fed an enriched AIN-93M diet that contains 33% higher content of protein, minerals, and vitamins per gram weight (Bio-Serv), at 67% of AL caloric intake. CR mice were given their food allotment on Mondays, Wednesdays, and Fridays, as described elsewhere (Pugh et al, 1999) . The dietary regimen lasted for 4 wk. Two weeks into each diet treatment, mice were given an intraperitoneal injection of 2 H 2 O (2.5% body water) and maintained on 4% 2 H 2 O in drinking water for the remaining 2 wk until euthanization. Epidermal cells were isolated and DNA enrichments were measured as described above.
Histology Sheets of epidermis were stained with hematoxylin and eosin (Histo-Tec Laboratory, Hayward, California) to confirm that epidermis was cleanly separated from dermis. The remaining dermis was also stained to confirm that all epidermis had been removed. Hematoxylin and eosin staining confirmed that tissues isolated consisted of epidermis and were not contaminated by dermis. Because dermis contains slowly proliferating fibroblasts, it is important to avoid dermal contamination, as this might alter apparent keratinocyte kinetics. Conversely, histology also showed that the dermis samples were free of epidermis. These results confirm that epidermis can be cleanly isolated by this method (Barlow and Pye, 1980; Dlugosz et al, 1995; Inokuchi et al, 1995) .
Statistical analyses
The two-tailed Student t test was used to analyze CR data. Lunasin and/or carcinogen treatment groups were compared by one-way ANOVA with Bonferroni follow-up at an error rate of 5%.
